Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Akshay Binayke und 17 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Core Laboratory, Translational Health Science and Technology Institute, Faridabad, India. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Cross Reactions, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Biotechnology Industry Research Assistance Council, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Emerging evidence shows increased humoral response post‐omicron surge, but research on T cell responses is limited. This study investigated the durability, magnitude, and breadth of SARS‐CoV‐2‐spike‐specific T cell responses in 216 two‐dose vaccinated individuals pre‐ and post‐omicron surge. Post‐surge samples showed enhanced T cell responses, indicating widespread asymptomatic exposure to omicron. Further analysis of 105 individuals with multiple exposures to SARS‐CoV‐2 through boosters or infections showed that post‐omicron, two‐dose vaccinated individuals had T cell responses comparable to those of COVID‐19 convalescents or boosted individuals. Additionally, we report cross‐reactive T cell responses against omicron sub‐variants, including BA2.86, remained strong, with preserved frequencies of spike‐specific stem‐cell‐like memory T cells. In silico prediction indicates that mutated epitopes of JN.1 and KP.2 retain over 95.6% of their HLA binding capability. Overall, our data suggests that T cell responses are sustained, enhanced, and cross‐reactive against emerging SARS‐CoV‐2 variants following symptomatic or asymptomatic omicron infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Core Laboratory, Translational Health Science and Technology Institute, Faridabad, India.
- Centre for Immunobiology and Immunotherapy, Translational Health Science and Technology Institute, Faridabad, India.
- Jawaharlal Nehru University, New Delhi, India.
- Translational Health Science and Technology Institute, Faridabad, India.
- ESIC Medical College and Hospital, Faridabad, India.
- All India Institute of Medical Science, New Delhi, India.
ORCID-Profile: Amit Awasthi
Förderung
- Biotechnology Industry Research Assistance Council
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Binayke, A., Zaheer, A., Vishwakarma, S., Sharma, P., Dandotiya, J., Raghavan, S., Gosain, M., Singh, S., Chattopadhyay, S., Kaushal, J., Madan, U., Kshetrapal, P., Batra, G., Wadhwa, N., Pandey, A. K., Bhatnagar, S., Garg, P. K., & Awasthi, A. (2024). Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge. Journal of Medical Virology. https://doi.org/10.1002/jmv.29877
Vancouver
Binayke A, Zaheer A, Vishwakarma S, Sharma P, Dandotiya J, Raghavan S, et al. Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge. Journal of Medical Virology. 2024. doi:10.1002/jmv.29877
BibTeX
@article{Binayke2024,
author = {Binayke, Akshay and Zaheer, Aymaan and Vishwakarma, Siddhesh and Sharma, Priyanka and Dandotiya, Jyotsna and Raghavan, Sreevatsan and Gosain, Mudita and Singh, Savita and Chattopadhyay, Souvick and Kaushal, Jyotsana and Madan, Upasna and Kshetrapal, Pallavi and Batra, Gaurav and Wadhwa, Nitya and Pandey, Anil Kumar and Bhatnagar, Shinjini and Garg, Pramod Kumar and Awasthi, Amit},
title = {Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29877}
}
EUVIMED